您的位置:首页 > 推荐期刊 > 期刊详情
推荐期刊
Clinical drug investigation
分享到:

影响因子:1.915

ISSN:1173-2563

出版社:Adis International

出版地:Mairangi Bay, Auckland, N.Z., Philadelphia

出版国家:New Zealand

刊期:月刊

创刊时间:1995

语种:英文

审稿周期:较慢,6-12周

中科院分区:4

投稿命中率:命中率约30.90%较易

国外数据收录:IMIM

中国收录文章数:23

5年影响因子:1.639

研究领域:临床试验专题、药物评价、药物治疗、药物研究、研究性新药申请、药物制剂

官方链接:http://link.springer.com/journal/40261

投稿须知:http://link.springer.com/journal/40261

期刊介绍:

Clinical Drug Investigation gives you rapid access to the best designed, peer reviewed clinical and pharmacoeconomic studies worldwide, allowing you to keep up to date with the latest original research in this exciting area. The Journal's aim is rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. This includes clinical trials, outcomes research, clinical pharmacoeconomic studies, pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs, clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice and, in some instances, pharmacodynamic or pharmacokinetic studies in healthy volunteers, but in which some established or purported implications for clinical prescribing are discussed. In addition, short communications and case study reports that meet these criteria are also encouraged, as are letters to the editor.

同领域期刊名称 影响因子

维普投稿-SCI专栏论文服务由广州品恒信息科技有限公司独立运营并承担相应的责任与义务

友情链接:维普网 | 维普投稿平台 | 维普论文检测 | 维普论文选题